The short version of freeze-thaw cycle fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-15 and is reviewed periodically as new material appears.
Quantification of NAD+ in biological samples usually relies on separation techniques coupled to sensitive detection. High-performance liquid chromatography with ultraviolet detection can measure the oxidized form by its absorbance near 260 nm, while mass spectrometry provides greater specificity and can distinguish NAD+ from close analogs. Enzymatic cycling assays use coupled dehydrogenase reactions to amplify signal and estimate NAD+ concentrations in cell or tissue extracts. Because NAD+ and NADH interconvert rapidly, sample preparation must quench metabolism quickly and preserve the redox state before analysis.
The stability of NAD+ depends on pH, temperature, light exposure, and the presence of degradative enzymes. Aqueous solutions are generally more stable under mildly acidic to neutral conditions and degrade faster under alkaline conditions or prolonged heat. The solid is hygroscopic and should be stored desiccated, often frozen, and protected from repeated freeze-thaw cycles. In laboratory handling, aliquots reduce repeated temperature changes, and chelating agents may limit metal-catalyzed hydrolysis in some buffers. These practices matter because even small amounts of NADH or hydrolysis products can interfere with quantitative assays.
Quality control for NAD+ materials typically combines identity, purity, and water content checks. Identity may be confirmed by ultraviolet spectrum, retention time in chromatography, or mass accuracy, while purity is assessed by HPLC peak area or quantitative nuclear magnetic resonance. Residual water and solvents can affect molar calculations and enzyme assays, so Karl Fischer titration or thermogravimetric analysis may be used. Commercial materials vary in grade and counterion form, and published methods should specify the exact salt or hydrate when reporting concentrations. Regulatory status depends on intended use, with research reagents, dietary ingredients, and clinical products treated under different frameworks.
NAD+ is relatively unstable in aqueous solution, especially at neutral or alkaline pH and at elevated temperatures. It is typically stored dry, protected from light and moisture, and kept cold or frozen for long-term use. Solutions are often prepared fresh or buffered to mildly acidic pH to slow hydrolysis. Repeated freeze-thaw cycles can reduce integrity. Laboratories may verify concentration using ultraviolet absorbance at 259 nm or by enzymatic assay. These handling practices are general laboratory conventions rather than universal rules.
Research on NAD+ often examines changes with age, diet, exercise, and disease states, but causal relationships are difficult to establish. Some studies measure NAD+ levels, while others assess enzyme activity or downstream markers. In the literature, terms such as "NAD+ decline" and "NAD+ boosting" appear in both scientific and commercial contexts, sometimes without precise definitions. Whether changes in measured NAD+ directly produce health effects remains an open question. Results from cells, animals, and humans cannot be assumed to translate directly.
Measuring NAD+ in biological samples requires rapid processing because the compound can degrade or interconvert after collection. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and mass spectrometry. Each method has different sensitivity, specificity, and susceptibility to interference from related nucleotides. Sample type matters: cultured cells, animal tissues, and human blood present distinct challenges. Reported values can vary widely across laboratories because of differences in extraction, normalization, and analytical platform. Standardization remains an open issue in the field.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated; avoid repeated freeze-thaw cycles. |
| Typical analytical method | LC-MS or HPLC with UV detection | Absorbance at 260 nm used for concentration estimates. |
| Reduced form absorbance | 340 nm | NADH absorbs at 340 nm; NAD+ does not. |
| Aqueous stability | pH-dependent | Degradation increases with alkaline pH and heat. |
| Purity check | HPLC purity and UV spectrum | Identity confirmed by retention time and absorbance ratio. |
Beyond electron transfer, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer ADP-ribose units. Sirtuins, poly(ADP-ribose) polymerases, and CD38 consume NAD+ in regulatory reactions. These activities link NAD+ availability to DNA repair, chromatin modification, calcium signaling, and metabolic stress responses. Because consumption can exceed biosynthesis under some conditions, cellular NAD+ levels are dynamic rather than fixed. Enzyme affinity and local synthesis also influence how much NAD+ is available for signaling.
NAD+ is a dinucleotide composed of adenine, ribose, and nicotinamide moieties linked by phosphate groups. Its oxidized form carries a positive charge on the nicotinamide ring, which enables reversible hydride transfer. The molecule functions as a coenzyme in oxidoreductase reactions rather than as a dietary vitamin in its intact form. Cells maintain separate pools in cytoplasm, mitochondria, and nucleus. This compartmentalization allows distinct redox environments while preserving a shared chemical identity.
In glycolysis, NAD+ accepts electrons during the oxidation of glyceraldehyde-3-phosphate, forming NADH. The tricarboxylic acid cycle and fatty acid oxidation also generate NADH, which donates electrons to the mitochondrial electron transport chain. This flow supports ATP synthesis and helps maintain the redox balance of the cell. Other dehydrogenases use NAD+ as a cofactor for biosynthetic reductions and detoxification reactions. NADH is later reoxidized to sustain continued flux through these pathways.
Solid NAD+ is relatively stable when kept dry, cold, and protected from light. Aqueous solutions are more vulnerable to hydrolysis and can lose activity during repeated freeze-thaw cycles or prolonged storage at ambient temperature. Stability depends on pH, ionic strength, and the presence of degrading enzymes or metal ions. For many laboratory uses, aliquots are stored frozen and thawed only once. Exact degradation rates vary by matrix, so stability should be checked for each application rather than assumed.
Laboratory handling of NAD+ follows standard practices for hygroscopic fine chemicals. Personnel typically avoid inhalation and skin contact, use gloves and eye protection, and work in a ventilated area. Quality control may include ultraviolet absorbance at the nicotinamide maximum, chromatographic purity, water content, and identity confirmation by mass spectrometry. Because commercial preparations can contain counterions, residual solvents, or related nucleotides, a certificate of analysis helps verify the material. Researchers should confirm that the form supplied matches the intended assay.
=== Other lawsuits, investigations, and prosecutions === In August 2019, Schmitt withdrew a legal brief that argued that the First Amendment allowed government officials to withhold records from a freedom of information request, following criticism from transparency advocates who noted that the brief did not cite any case law. A Freedom Center of Missouri representative raised concern that the argument is similar to a case involving Governor Mike Parson, which Schmitt had not yet ruled on. Under Schmitt, the attorney general's office sued the city of Marshfield, Missouri, alleging that it maintained a ticket-quota system, in violation of the state law Schmitt had sponsored as state senator banning such quotas. In 2020, the suit ended in a settlement in which the city agreed to maintain a compliance program and have its state officials undergo training on the law. In September 2019, a bipartisan group of state attorneys general, including Schmitt, launched an antitrust investigation against Google. The attorneys general accused Google of prioritizing searches for companies that advertise on the search engine platform in violation of antitrust law.
Paralytic shellfish poisoning (PSP) is one of the four recognized syndromes of shellfish poisoning, which share some common features and are primarily associated with bivalve mollusks (such as mussels, clams, oysters and scallops). These shellfish are filter feeders and accumulate neurotoxins, chiefly saxitoxin, produced by microscopic algae, such as dinoflagellates, diatoms, and cyanobacteria. Dinoflagellates of the genus Alexandrium are the most numerous and widespread saxitoxin producers and are responsible for PSP blooms in subarctic, temperate, and tropical locations. The majority of toxic blooms have been caused by the morphospecies Alexandrium catenella, Alexandrium tamarense, Gonyaulax catenella and Alexandrium fundyense, which together comprise the A. tamarense species complex. In Asia, PSP is mostly associated with the occurrence of the species Pyrodinium bahamense. Some pufferfish, including the chamaeleon puffer, also contain saxitoxin, making their consumption hazardous.
CpG site Also CG site and C-G site. A sequence of DNA in which a cytosine nucleotide is immediately followed by a guanine nucleotide on the same strand in the 5'-to-3' direction; the "p" in CpG refers simply to the intervening phosphate group linking the two consecutive nucleotides.
A harmful, or deleterious, mutation decreases the fitness of the organism. Many, but not all mutations in essential genes are harmful (if a mutation does not change the amino acid sequence in an essential protein, it is harmless in most cases). A beneficial, or advantageous mutation increases the fitness of the organism. Examples are mutations that lead to antibiotic resistance in bacteria (which are beneficial for bacteria but usually not for humans). A neutral mutation has no harmful or beneficial effect on the organism. Such mutations occur at a steady rate, forming the basis for the molecular clock. In the neutral theory of molecular evolution, neutral mutations provide genetic drift as the basis for most variation at the molecular level. In animals or plants, most mutations are neutral, given that the vast majority of their genomes is either non-coding or consists of repetitive sequences that have no obvious function ("junk DNA"). Synonymous mutations, that is mutations that do not change the amino acid sequence of a protein, rarely have fitness effects, but sometimes they do. For example, the sequence of an altered mRNA can lead to an altered RNA structure or stability which may affect protein synthesis. Large-scale quantitative mutagenesis screens, in which thousands of millions of mutations are tested, invariably find that a larger fraction of mutations has harmful effects but always returns a number of beneficial mutations as well. For instance, in a screen of all gene deletions in E.
Sources: en.wikipedia.org
=== Thyroid gland === The thyroid gland develops from two different clusterings of embryonic cells. One part is from the thickening of the pharyngeal floor, which serves as the precursor of the thyroxine (T4) producing follicular cells. The other part is from the caudal extensions of the fourth pharyngobranchial pouches which results in the parafollicular calcitonin-secreting cells. These two structures are apparent by 16 to 17 days of gestation. Around the 24th day of gestation, the foramen cecum, a thin, flask-like diverticulum of the median anlage develops. At approximately 24 to 32 days of gestation the median anlage develops into a bilobed structure. By 50 days of gestation, the medial and lateral anlage have fused together. At 12 weeks of gestation, the fetal thyroid is capable of storing iodine for the production of TRH, TSH, and free thyroid hormone. At 20 weeks, the fetus is able to implement feedback mechanisms for the production of thyroid hormones. During fetal development, T4 is the major thyroid hormone being produced while triiodothyronine (T3) and its inactive derivative, reverse T3, are not detected until the third trimester.
=== Research directions === Several challenges remain to be addressed for widespread adoption and integration of theranostics into routine clinical practice. Regulatory considerations will play a role in ensuring the safety, efficacy, and quality of theranostic agents and technologies. Harmonization of regulations across different countries and regions is necessary to facilitate global implementation. Cost-effectiveness is a significant challenge, as theranostic approaches can be expensive. Strategies to optimize resource utilization and reimbursement models have been discussed. Technical limitations, such as the development of more specific and sensitive imaging agents, improvement of imaging resolution and quality, and the integration of different imaging modalities, require ongoing research and technological advancements. Ethical considerations surrounding patient privacy, data security, and the responsible use of patient information need to be addressed.
== External links == Vincent du Vigneaud on Nobelprize.org including the Nobel Lecture, December 12, 1955 A Trail of Sulfa Research: From Insulin to Oxytocin https://weill.cornell.edu/archives/pdf/personal_aids/DuVigneaud.pdf
== Prognosis == The prognosis of this sub-type of MD indicates that the affected individual may eventually have feeding difficulties. Surgery, at some point, might be an option for scoliosis. Scoliosis, which is a sideways curve of the persons vertebrate, is determined by a variety of factors, including the degree (mild or severe), in which case if possible a brace might be used by the individual.
=== Addiction treatment === A 2022 systematic review suggests that ibogaine and noribogaine show promise in treating substance use disorders and comorbid depressive symptoms and psychological trauma, but carry serious safety risks, necessitating rigorous clinical oversight. A 2023 review found that ibogaine and noribogaine show some potential in treating substance use disorders, especially opiate detoxification, but that their efficacy is unconfirmed and use carries significant cardiotoxic and mortality risks. A total of two randomized controlled trials have been conducted on ibogaine and noribogaine.
Sources: en.wikipedia.org
==== Charitable contributions tax deduction ==== Effective January 1, 2026, the law allows a tax deduction for charitable contributions made in cash by an individual who does not itemize their tax deductions. The deduction is limited to $1,000 (or $2,000 if married filing jointly). The deduction is not allowed for contributions to donor-advised funds or private non-operating foundations. Carrying over excess charitable contributions to other years is not allowed if the person does not itemize their tax deductions. Effective January 1, 2026, for individuals who itemize their tax deductions, a tax deduction is allowed only for the amount that exceeds 0.5 percent of their adjusted gross income. The law makes permanent a temporary limit on cash tax deductions for charitable contributions of up to 60 percent of their adjusted gross income to 501(c)(3) public charities. This only applies if the individual itemizes their tax deductions. Effective January 1, 2026, the tax benefit for charitable contributions made by an individual that itemizes their tax deductions is limited to 35% of the amount contributed, even if they are in a marginal tax bracket higher than 35%.
In December 2022, NBC News reported in a television segment that some TikTok and YouTube influencers were being given free and discounted cosmetic surgeries in order for them to advertise the surgeries to users of the platforms. In 2022, it was reported that a trend called "de-influencing" had become popular on the platform as a backlash to influencer marketing. TikTok creators participating in this trend made videos criticizing products promoted by influencers and asked their audiences not to buy products they did not need. However, some creators participating in the trend started promoting alternative products to their audiences and earning commission from sales made through their affiliate links in the same manner as the influencers they were originally criticizing. In June 2022, NBC News reported that some of the influencers paid by FeetFinder, a website that sells foot fetish content, did not disclose their videos were ads. FeetFinder said that it has suggested to influencers to be upfront about who was funding them. Existing sellers on FeetFinder said that the videos often misrepresented how "easy" it is to make money from posting feet pictures. Other TikTok creators have spoken out against accepting sponsorship deals indiscriminately and criticized those who posted undisclosed FeetFinder ads.
Jonathan Rhoads, was the first to successfully nourish initially Beagle puppies and subsequently newborn babies with catastrophic gastrointestinal malignancies. Dudrick collaborated with Dr. Willmore and Dr. Vars to complete the work necessary to make this nutritional technique safe and successful. He showed that a central venous catheter could be used to administer the infusion fluid intravenously. Presented with Judy Ellis Taylor in September 1970 who had all her bowels surgically removed due to gangrene, gastroenterologist and University of Toronto clinical researcher Dr. Khursheed Nowrojee Jeejeebhoy, who'd been working with short-term hyperalimentation (as TPN was then called) at Toronto General Hospital, determined to create complete nutrition and send her home to live on it. Taylor was the first person in the world to live without eating, receiving no calories or nutrition by mouth, unlike previous patients, and to live at home and care for her family. As a result, Jeejeebhoy was able to demonstrate a person could live at home with good quality of life on TPN, that fatty liver develops as a result of carbohydrates not fat, discover that chromium is involved in the development of diabetes, investigate the role of zinc, and study the effect of intravenous Vitamin D on the development of osteomalacia and parenteral nutrition-induced metabolic bone disease, among other discoveries. Prof. Wretlind called him, "the father of complete long-term parenteral nutrition in man." And in the 2009 biography in the journal Gastroenterology, the author Myron Lewis dubbed him, "Mr.
Common synthetic polymers include polyvinyl alcohol, polyethylene glycol, sodium polyacrylate, acrylate polymers and copolymers thereof. Whereas natural hydrogels are usually non-toxic, and often provide other advantages for medical use, such as biocompatibility, biodegradability, antibiotic/antifungal effect and improve regeneration of nearby tissue, their stability and strength is usually much lower than synthetic hydrogels. There are also synthetic hydrogels that can be used for medical applications, such as polyethylene glycol (PEG), polyacrylate, and polyvinylpyrrolidone (PVP).
Sources: en.wikipedia.org
Common methods include LC-MS, HPLC with UV detection, and enzymatic cycling assays. Rapid quenching is needed because NAD+ and NADH interconvert. The chosen method should be validated for the sample matrix.
Solid NAD+ is typically stored desiccated at -20 °C or lower. Aqueous solutions are less stable and should be prepared fresh or frozen in aliquots. Repeated freeze-thaw cycles can reduce integrity.
NADH, NAD+ analogs, hydrolysis products, and residual solvents can interfere. Buffer pH and metal ions may also affect stability or enzyme activity. Blank controls and calibration curves help identify such problems.
Researchers often use enzymatic cycling assays, liquid chromatography, or mass spectrometry. The choice depends on sample size, sensitivity needs, and available equipment. Because NAD+ can degrade quickly, rapid extraction and careful handling are important.